Thomas Patrick Reeves
Directeur Général chez Interface Biologics, Inc.
Profil
Thomas Patrick Reeves is currently the President, Chief Executive Officer & Director at Interface Biologics, Inc. He previously served as the President & Chief Executive Officer at Borderfree Ltd.
from 2001 to 2004.
He also held the position of Managing Director-European Region at Merisel (UK) Ltd.
Additionally, he was the President & Chief Operating Officer at TearLab Corporation, Inc. from 2004 to 2008.
Prior to that, he was the President at Beamscope Canada, Inc. from 1998 to 2000 and the Principal at The Boston Consulting Group, Inc. He started his career as the President at Merisel Canada, Inc. from 1994 to 1998.
Mr. Reeves completed his undergraduate degree at Harvard University and his graduate degree at Australian National University.
Postes actifs de Thomas Patrick Reeves
Sociétés | Poste | Début |
---|---|---|
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Directeur Général | 01/11/2008 |
Anciens postes connus de Thomas Patrick Reeves
Sociétés | Poste | Fin |
---|---|---|
TEARLAB CORPORATION | President | 30/06/2008 |
Borderfree Ltd. | Directeur Général | 01/09/2004 |
Beamscope Canada, Inc. | President | 01/01/2000 |
Merisel Canada, Inc.
Merisel Canada, Inc. Electronics DistributorsDistribution Services Part of TD SYNNEX Corp., Merisel Canada, Inc. distributes computer products. The company is based in Toronto, Canada. Merisel Canada was acquired by TD SYNNEX Corp. from Merisel, Inc. on July 30, 2001 for $19.80 million. | President | 01/01/1998 |
Merisel (UK) Ltd.
Merisel (UK) Ltd. Commercial Printing/FormsCommercial Services Part of Merisel, Inc., Merisel (UK) Ltd. is a company based in Brentford, UK. | Corporate Officer/Principal | - |
Formation de Thomas Patrick Reeves
Harvard University | Undergraduate Degree |
Australian National University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 7 |
---|---|
TearLab Corporation, Inc.
TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Southlake, TX. | Health Technology |
Beamscope Canada, Inc. | Distribution Services |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Merisel Canada, Inc.
Merisel Canada, Inc. Electronics DistributorsDistribution Services Part of TD SYNNEX Corp., Merisel Canada, Inc. distributes computer products. The company is based in Toronto, Canada. Merisel Canada was acquired by TD SYNNEX Corp. from Merisel, Inc. on July 30, 2001 for $19.80 million. | Distribution Services |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Technology Services |
Borderfree Ltd. | Technology Services |
Merisel (UK) Ltd.
Merisel (UK) Ltd. Commercial Printing/FormsCommercial Services Part of Merisel, Inc., Merisel (UK) Ltd. is a company based in Brentford, UK. | Commercial Services |